Validating a bleeding risk score for stomach bleeding
Part of Digestive system clinical trials.
This study checks how well a risk score predicts the need for treatment in patients with upper gastrointestinal bleeding (bleeding in the stomach or esophagus). It may help doctors decide if you need urgent care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have bleeding from your stomach or esophagus that started on its own (not from an injury)
- You are not bleeding from external hemorrhoids or sores in the mouth
- You agree to participate and can be followed up by the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication to help stop bleeding in the upper part of the stomach and esophagus. It may offer a new option for people with this urgent condition.
This study is testing different ways to use blood transfusions in emergency situations to improve survival and recovery for people with severe bleeding from injury or stomach/intestinal bleeding. The goal is to find the best transfusion approach to help patients like you.
This study aims to create a tool that helps doctors predict if a patient with upper gut bleeding (not from veins) will rebleed while still in the hospital. It uses information from your hospital stay to better understand your risk and improve care.
This study checks whether a score called CAGIB can accurately predict the risk of dying during the hospital stay for people with cirrhosis who have sudden bleeding in the digestive tract. It may help doctors identify who needs the most urgent care and monitor outcomes more accurately.
This study checks whether a simple blood test score (called HALP) can help predict which people with upper gastrointestinal bleeding are more likely to have serious complications. The goal is to find patients who need closer monitoring or quicker treatment.
This study looks at patients who develop bleeding in the stomach or intestines while in the intensive care unit (ICU). It aims to understand how common this is and what factors might be involved, which could help improve care for future patients.
Hear when a new Upper Gastrointestinal Bleeding (UGIB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.